Cemax display stations win FDA nod
PACS developer Cemax is puttingthe regulatory pieces together for its line of image managementand archiving products. Cemax received Food and Drug Administration510(k) marketing clearance last month for its ClinicalView andDiagnosticView workstations,
PACS developer Cemax is puttingthe regulatory pieces together for its line of image managementand archiving products. Cemax received Food and Drug Administration510(k) marketing clearance last month for its ClinicalView andDiagnosticView workstations, two of the products in the Fremont,CA, vendor's Perfect Vision series of display technology.
ClinicalView is a Sun-based display station designed for nurses,physicians and technologists at hospital locations outside theradiology department, such as emergency and critical care units.The workstation has a resolution of 1280 x 1600 on a 24-inch portraitmonitor.
DiagnosticView, also a Sun-based system, is a review stationwith 2000 x 2000-pixel resolution, 21-inch portrait monitors foruse by radiologists. Both workstations support Fuji and Du Pontcomputed radiography devices and interfaces with Lumisys and DuPont digitizers.
The display stations archive to 8-mm digital tape and aresupported by the company's ImageServer distributed image managementand archiving architecture. Cemax received FDA clearance for itsImageServer software last year (SCAN 12/29/93).
Cemax signed a joint sales and marketing agreement with 3Min February for the Perfect Vision products. 3M unveiled the Cemaxline as the 3M Image Management System at last month's AmericanInstitute of Ultrasound in Medicine meeting.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study: Black Patients Less Likely Than Others to Receive MRI Assessment of Cognitive Impairment
November 27th 2023In a four-year study of over 1,600 patients who had outpatient head CTs, head CT angiography and/or brain MRI to assess cognitive impairment, researchers found that Black patients were over 9 percent less likely than White patients and over 16 percent less likely than Hispanic patients to receive brain MRI.
